novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Wegovy's heart benefits are not just linked with weight loss, new study suggests Eli Lilly said its new

Cagrilintide added to tirzepatide represents a more advanced combination targeting the amylin pathway in addition to GLP-1 and GIP

Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ

Ultimately, this data aligns with conclusions from regulatory bodies like the FDA, which, after its own review, stated it has "not found evidence that use of these medications causes suicidal thoughts or actions." Takeaway 3: Who Was Studied Matters, A Critical Caveat While the results are broadly reassuring, it is crucial to understand who was included in these trials

The result: the person thinks Zepbound has caused fresh balding, when in fact the AGA was already present and is only now becoming visible

But persistent symptoms require assessment

We prioritize safety and sustainable results over speed or volume